Granulocyte colony-stimulating factor

Sep 20, 2019

Global Neutropenia Treatment Market Report 2019-2027

Mar 27, 2019

BioLineRx Announces Successful Engraftment Data From Phase 3 GENESIS Trial for BL-8040 in Multiple Myeloma Patients

Feb 28, 2019

Patient access to cost-effective treatments increased with launch of new biosimilar in Canada

Aug 07, 2018

BioLineRx Announces Positive Results of Lead-in Period for Phase 3 GENESIS Trial in Stem-Cell Mobilization

Apr 27, 2018

Bolder BioTechnology Announces Positive Results from Phase 1 Clinical Trial of BBT-015, a Long-Acting G-CSF Analog, in Healthy Volunteers

Dec 21, 2017

BioLineRx Announces Initiation of Phase 3 GENESIS Trial in Stem-Cell Mobilization for Autologous Transplantation in Multiple Myeloma Patients

Oct 24, 2017

Award-Winning Journalist And Cancer Survivor Joan Lunden Partners With Amgen To Launch 'At Home With Joan' To Empower Patients Battling Cancer

Aug 21, 2017

BioLineRx Announces Regulatory Submission of Phase 3 Registrational Study for BL-8040 in Stem Cell Mobilization

Aug 02, 2017

Bolder BioTechnology Announces Initiation of Phase 1 Clinical Trial of BBT-015 for Treating Neutropenia and Acute Radiation Syndrome

Jun 19, 2017

Enzychem Lifesciences Announces Initiation of Global Phase 2 Trial of EC-18 in Patients with Chemotherapy Induced Neutropenia(CIN)